More stories
ARPA-H Launches $100M Effort to “Demystify” Mental Health and Catalyse Rapid-Acting Behavioural Health Therapeutics,...
The Advanced Research Projects Agency for Health (ARPA-H) has carved out up to $100M for an initiative that aims to develop objective measures of...
Evelyn Eddy Shoop MSN, APRN, PMHNP-BC: Lived Experience, Qualitative Data, and the Future of...
Overview Evelyn Eddy Shoop PMHNP-BC joins Psychedelics Today to share her journey from Division I athlete to psychiatric mental health nurse practitioner and psilocybin...
Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b Debrief; UK Government...
Last Issue, we reported the publication of a small (N=19), open-label trial of LSD microdosing for major depressive disorder (MDD) that saw a 59.5%...
Dr Jason Konner – Psychedelic Oncology and the Future of Cancer Care
In this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at Memorial Sloan...
The Psychedelic News Feed: November 3 – 9, 2025
This is an archived version of our Psychedelic News Feed. Explore the live Feed and receive a weekly digest to your inbox by joining...
The Psychedelic News Feed: November 10 – 16, 2025
This is an archived version of our Psychedelic News Feed. Explore the live Feed and receive a weekly digest to your inbox by joining...
Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action
As psychedelic treatments gain traction across Europe, Dr. Óscar Soto is helping shape their future from Barcelona. Dr. Soto is a psychiatrist, therapist, and...
Ayahuasca Podcast: Joe Moore – Safe Access, Breathwork and Building a Psychedelic Informed World
In this episode of Ayahuasca Podcast host Sam Believ has a conversation with Joe Moore, co-founder & CEO of Psychedelics Today. Joe is a...
In Aspen, a Bipartisan Strategy for Ibogaine Takes Shape as Advocates Confront the Limits...
ASPEN, Colorado — The drive into the Aspen Meadows Resort, with its open mountain views and Bauhaus-inspired architecture, offered a tranquil approach to what...
Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration
Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS...
AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots Phase 3
This morning, AtaiBeckley shared positive topline data from the open-label portion of its Phase 2b trial of intranasal 5-MeO-DMT (BPL-003) in patients with treatment-resistant...
Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy...
The largest news story this week came from Compass Pathways, as the psilocybin developer announced on Tuesday that it is bringing forward its launch...
